Page last updated: 2024-09-03

pd 128483 and 4-butyrolactone

pd 128483 has been researched along with 4-butyrolactone in 1 studies

Compound Research Comparison

Studies
(pd 128483)
Trials
(pd 128483)
Recent Studies (post-2010)
(pd 128483)
Studies
(4-butyrolactone)
Trials
(4-butyrolactone)
Recent Studies (post-2010) (4-butyrolactone)
5004,456781,823

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Caprathe, BW; Christoffersen, CL; Corbin, AE; Jaen, JC; Meltzer, LT; Ninteman, FW; Pugsley, TA; Serpa, KA; Shih, YH; Whetzel, SZ1

Other Studies

1 other study(ies) available for pd 128483 and 4-butyrolactone

ArticleYear
Pharmacological profile of the dopamine partial agonist, (+/-)-PD 128483 and its enantiomers.
    The Journal of pharmacology and experimental therapeutics, 1993, Volume: 266, Issue:3

    Topics: 4-Butyrolactone; Aminoquinolines; Amphetamine; Animals; Apomorphine; Avoidance Learning; Behavior, Animal; Cebus; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Extrapyramidal Tracts; Male; Mice; Motor Activity; Neurons; Norepinephrine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Saimiri; Serotonin; Stereoisomerism; Stereotyped Behavior; Stimulation, Chemical; Thiazoles

1993